Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*

标题
Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*
作者
关键词
-
出版物
CRITICAL CARE MEDICINE
Volume 38, Issue 1, Pages 72-83
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2009-12-17
DOI
10.1097/ccm.0b013e3181b07b78

向作者/读者发起求助以获取更多资源

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started